Stock Rich List
#2224 on the rich list of 14,452 insiders

Andrew Paul Mazar

Chief Scientific Officer at Monopar Therapeutics; Chief Operating Officer at Actuate Therapeutics, Inc. Common stock. Based in Fort Worth, Texas.

$60.5M
in disclosed stock, −$400K (−0.66%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
2224th of 14,452
Companies held
2
Largest holding
MNPR, 100.0% of total
Latest SEC filing
Aug 12, 2024

What the $60.5M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Monopar Therapeutics MNPR
Common Stock
Through TacticGem LLC822,255
split-adjusted
$70.29$57.8M95.6%Form 4, Mar 31, 2022
Monopar Therapeutics MNPR
Common Stock
Through Tactic Pharma LLC33,333
split-adjusted
$70.29$2.3M3.9%Form 4, Mar 31, 2022
Monopar Therapeutics MNPR
Common Stock
Directly4,425
split-adjusted
$70.29$311K0.5%Form 4, Mar 31, 2022
Actuate Therapeutics, Inc. Common stock ACTU
Common Stock
Directly127,250$0.21$27K0.0%Form 3, Aug 12, 2024

Share counts are the amounts Andrew Paul Mazar reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2221Jonathan Hirt Hagen
Director, Erie Indemnity. Philadelphia, PA
$60.5M−$1.6M (−2.62%)
2222Patrick J. Healy
Director, Medline. San Francisco, CA
$60.5M−$2.1M (−3.37%)
2223Brian Harris
Chief Executive Officer, Ladder Capital. New York, NY
$60.5M−$292K (−0.48%)
2224Andrew Paul Mazar
Chief Scientific Officer, Monopar Therapeutics. Fort Worth, TX
$60.5M−$400K (−0.66%)
2225Robert M. Friedland
Executive Chairman, Ivanhoe Electric. Tempe, AZ
$60.4M−$2.3M (−3.68%)
2226Arthur G. Sulzberger
Chairman and Publisher, The New York Times. New York, NY
$60.3M−$1.5M (−2.49%)
2227Thomas M. Wojcik
President and COO, Affiliated Managers Group. West Palm Beach, FL
$60.3M−$2.3M (−3.65%)

Other Monopar Therapeutics insiders

All MNPR insiders

Questions

How much stock does Andrew Paul Mazar own?

Andrew Paul Mazar holds $60,477,515 in listed stock based on SEC filings and current prices, mostly Monopar Therapeutics (MNPR). That ranks 2224th on the Stock Rich List.

Is this Andrew Paul Mazar's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.